PCVX
Vaxcyte Inc

752
Mkt Cap
$8.71B
Volume
60.00
52W High
$83.33
52W Low
$27.66
PE Ratio
-12.46
PCVX Fundamentals
Price
$61.35
Prev Close
$60.26
Open
$60.68
50D MA
$50.38
Beta
0.75
Avg. Volume
1.3M
EPS (Annual)
-$3.80
P/B
2.76
Rev/Employee
$0.00
$8,310.60
Loading...
Loading...
News
all
press releases
Vaxcyte Q4 Earnings Call Highlights
Vaxcyte (NASDAQ:PCVX) executives used the company's fourth-quarter and full-year 2025 earnings call to highlight progress in late-stage development of its pneumococcal conjugate vaccine (PCV...
MarketBeat·9h ago
News Placeholder
More News
News Placeholder
Vaxcyte (NASDAQ:PCVX) Issues Quarterly Earnings Results
Vaxcyte (NASDAQ:PCVX - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($1.80) earnings per share (EPS) for the quarter, missing the consensus estimate of...
MarketBeat·13h ago
News Placeholder
Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
OVV is expected to report lower revenues than in the year-ago period. However, the company is also expected to have faced reduced costs and expenses.
Zacks·7d ago
News Placeholder
Aberdeen Group plc Boosts Holdings in Vaxcyte, Inc. $PCVX
Aberdeen Group plc raised its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 70.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·7d ago
News Placeholder
Vaxcyte (PCVX) to Release Quarterly Earnings on Tuesday
Vaxcyte (NASDAQ:PCVX) will be releasing its Q4 2025 earnings after the market closes on Tuesday, February 24. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
Vaxcyte Spotlights VAX-31 Phase 3 Launch, Eyes Adult BLA by End of Next Year at Biotech Summit
Vaxcyte (NASDAQ:PCVX) executives used a presentation at an annual biotech summit to highlight progress across the company's pneumococcal conjugate vaccine (PCV) pipeline, with a particular focus on...
MarketBeat·11d ago
News Placeholder
Vaxcyte, Inc. $PCVX Shares Bought by Federated Hermes Inc.
Federated Hermes Inc. raised its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 6,856.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·17d ago
News Placeholder
Top Biotech Stocks To Follow Today - February 1st
Danaher, Vertex Pharmaceuticals, Moderna, Vaxcyte, argenex, VivoSim Labs, and ImmunityBio are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...
MarketBeat·24d ago
News Placeholder
Biotech Stocks To Keep An Eye On - January 31st
Danaher, Vertex Pharmaceuticals, Moderna, Vaxcyte, argenex, VivoSim Labs, and ImmunityBio are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...
MarketBeat·25d ago
News Placeholder
Biotech Stocks To Follow Today - January 30th
Danaher, VivoSim Labs, Moderna, Vaxcyte, and Dianthus Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies...
MarketBeat·26d ago
<
1
2
...
>

Latest PCVX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.